Ferrer Internacional Drug Patent Portfolio
Ferrer Internacional owns 1 orange book drug protected by 3 US patents Given below is the list of Ferrer Internacional's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9180200 | Pharmaceutical topical compositions | 29 Jan, 2032 | Active |
| US9399014 | Pharmaceutical topical compositions | 15 Dec, 2029 | Active |
| US6335447 | Quinolonecarboxylic acid derivatives or salts thereof | 09 Nov, 2023 | Expired |
Latest Legal Activities on Ferrer Internacional's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ferrer Internacional.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Jan, 2024 | US9399014 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Jan, 2020 | US9399014 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 Jul, 2016 | US9399014 |
|
Recordation of Patent Grant Mailed
Critical
| 26 Jul, 2016 | US9399014 |
|
Email Notification
Critical
| 06 Jul, 2016 | US9399014 |
|
Issue Notification Mailed
Critical
| 05 Jul, 2016 | US9399014 |
| Dispatch to FDC | 23 Jun, 2016 | US9399014 |
|
Application Is Considered Ready for Issue
Critical
| 22 Jun, 2016 | US9399014 |
|
Issue Fee Payment Verified
Critical
| 22 Jun, 2016 | US9399014 |
|
Issue Fee Payment Received
Critical
| 22 Jun, 2016 | US9399014 |
| Response to Reasons for Allowance | 07 Jun, 2016 | US9399014 |
|
Email Notification
Critical
| 09 May, 2016 | US9399014 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 09 May, 2016 | US9399014 |
|
Response to Amendment under Rule 312
Critical
| 05 May, 2016 | US9399014 |
|
Amendment after Notice of Allowance (Rule 312)
Critical
| 04 May, 2016 | US9399014 |
Ferrer Internacional's Family Patents
Ferrer Internacional Drug List
Given below is the complete list of Ferrer Internacional's drugs and the patents protecting them.
1. Xepi
Xepi is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9180200 | Pharmaceutical topical compositions |
29 Jan, 2032
(6 years from now)
| Active |
| US9399014 | Pharmaceutical topical compositions |
15 Dec, 2029
(4 years from now)
| Active |
| US6335447 | Quinolonecarboxylic acid derivatives or salts thereof |
09 Nov, 2023
(1 year, 11 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xepi's drug page